Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
Recruiting
Phase 4
Interventional Study
Heart Failure
Heart Failure - NYHA II - IV
Heart Failure Acute
Acute Heart Failure (AHF)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 600 (estimated)
- Sponsor
- Lakeland Regional Health Systems, Inc. · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care.
The main questions it aims to answer are:
1. Does targeting a higher urine sodium goal achieve greater natriuresis and …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The study will target adults 18 years of age or older admitted to Lakeland Regional Medical Center who:
* Have a primary diagnosis of acute decompensated heart failure, and
* Have at least one of the following signs of hypervolemia:
* Bilateral lower extremity pittin…
Contacts